InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 19.60
+0.34 (1.77%)
Sep 8, 2026, 4:00 PM EDT
InventisBio Market Cap
InventisBio has a market cap or net worth of 11.36 billion as of September 8, 2026. Its market cap has decreased by -52.86% in one year.
Market Cap
11.36B
Enterprise Value
10.05B
Revenue
71.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.60
ChartMarket Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 11.36B, an increase of 29.21%. That is a compound annual growth rate of 6.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 11.36B | -27.89% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HitGen | 12.60B |
| GemPharmatech | 12.57B |
| Shanghai Medicilon | 12.27B |
| Mabwell (Shanghai) Bioscience | 11.76B |
| Chengdu Olymvax Biopharmaceuticals | 11.45B |
| Tibet Cheezheng Tibetan Medicine | 11.28B |
| Sino Biological,Inc. | 11.18B |
| Inner Mongolia Furui Medical Science | 11.17B |